Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 207–207 | Cite as

Pembrolizumab

Pneumonitis: case report
Case report
  • 7 Downloads

Reference

  1. Suo AE, et al. Pembrolizumab-induced immune related adverse events and survival outcomes in advanced melanoma. Journal of Clinical Oncology 36 (Suppl. 1): no pagination abstr. e21577, No. 15, 2018. Available from: URL: http://doi.org/10.1200/JCO.2018.36.15-suppl.e21577 [abstract] - Canada

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations